Justine Clark

469 total citations
9 papers, 248 citations indexed

About

Justine Clark is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Justine Clark has authored 9 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Justine Clark's work include Acute Myeloid Leukemia Research (2 papers), Viral-associated cancers and disorders (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Justine Clark is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Viral-associated cancers and disorders (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Justine Clark collaborates with scholars based in United States, Netherlands and Belgium. Justine Clark's co-authors include Lubomir Sokol, Alan F. List, Kathy L. McGraw, Gisela Cáceres, Joseph Johnson, Rami S. Komrokji, Jaroslaw P. Maciejewski, Lynn C. Moscinski, Gerard J. Nuovo and Dung‐Tsa Chen and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Justine Clark

9 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Justine Clark United States	8	153	138	59	48	46	9	248
Purvi M. Kakadia Germany	10	208 1.4×	195 1.4×	92 1.6×	54 1.1×	46 1.0×	28	349
Josephine Kahn United States	2	130 0.8×	141 1.0×	76 1.3×	49 1.0×	28 0.6×	3	236
Jennifer Richmond Australia	7	140 0.9×	137 1.0×	33 0.6×	33 0.7×	101 2.2×	12	334
Kathleen C. Rayeroux Australia	6	109 0.7×	109 0.8×	91 1.5×	34 0.7×	50 1.1×	10	224
Laura García-Ortí Spain	5	161 1.1×	311 2.3×	73 1.2×	77 1.6×	58 1.3×	6	397
Zhihong J. Wang United States	6	136 0.9×	181 1.3×	79 1.3×	18 0.4×	69 1.5×	10	314
Elena Vendramini Italy	7	69 0.5×	150 1.1×	54 0.9×	73 1.5×	46 1.0×	10	232
Camino Estivill Spain	11	195 1.3×	174 1.3×	78 1.3×	43 0.9×	45 1.0×	21	328
Justin Tibbitts United States	5	135 0.9×	250 1.8×	53 0.9×	49 1.0×	31 0.7×	7	310
Sylvie Lavallée Canada	5	143 0.9×	290 2.1×	39 0.7×	54 1.1×	75 1.6×	7	384

Countries citing papers authored by Justine Clark

Since Specialization

Citations

This map shows the geographic impact of Justine Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justine Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justine Clark more than expected).

Fields of papers citing papers by Justine Clark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justine Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justine Clark. The network helps show where Justine Clark may publish in the future.

Co-authorship network of co-authors of Justine Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Justine Clark. A scholar is included among the top collaborators of Justine Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justine Clark. Justine Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Kahen, Elliot, Diana Yu, Douglas J. Harrison, et al.. (2016). Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma. Cancer Chemotherapy and Pharmacology. 78(2). 313–323. 17 indexed citations

Basiorka, Ashley A., Kathy L. McGraw, Leentje De Ceuninck, et al.. (2016). Lenalidomide Stabilizes the Erythropoietin Receptor by Inhibiting the E3 Ubiquitin Ligase RNF41. Cancer Research. 76(12). 3531–3540. 24 indexed citations

McGraw, Kathy L., Ashley A. Basiorka, Joseph Johnson, et al.. (2014). Lenalidomide Induces Lipid Raft Assembly to Enhance Erythropoietin Receptor Signaling in Myelodysplastic Syndrome Progenitors. PLoS ONE. 9(12). e114249–e114249. 21 indexed citations

Wei, Sheng, X Chen, Kathy L. McGraw, et al.. (2012). Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion. Oncogene. 32(9). 1110–1120. 74 indexed citations

McGraw, Kathy L., Gwenny M. Fuhler, Joseph Johnson, et al.. (2012). Erythropoietin Receptor Signaling Is Membrane Raft Dependent. PLoS ONE. 7(4). e34477–e34477. 26 indexed citations

Cáceres, Gisela, Robert W. Robey, Lubomir Sokol, et al.. (2012). HG-829 Is a Potent Noncompetitive Inhibitor of the ATP-Binding Cassette Multidrug Resistance Transporter ABCB1. Cancer Research. 72(16). 4204–4213. 14 indexed citations

Sokol, Lubomir, Gisela Cáceres, Stefano Volinia, et al.. (2011). Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes. British Journal of Haematology. 153(1). 24–32. 59 indexed citations

Basiorka, Ashley A., Kathy L. McGraw, Justine Clark, et al.. (2011). Lenalidomide Upregulates Erythropoietin Receptor Expression in Hematopoietic Progenitors by Modulating Receptor Turnover. Blood. 118(21). 2382–2382. 2 indexed citations

List, Alan F., Kathy Rocha, Ling Zhang, et al.. (2009). Secondary Resistance to Lenalidomide in Del(5q) MDS Is Associated with CDC25C & PP2A Overexpression.. Blood. 114(22). 292–292. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact